Among these SNPs, heterozygous carriers of the ERCC2 751AC genotype had a 1.66-fold risk of lung adenocarcinoma compared with those carrying the homozygous wild genotype (95%CI 1.07-2.59, P = 0.024). Here, ERCC2 is linked to lung adenocarcinoma.